Close Menu

NEW YORK – Direct-to-consumer custom probiotics and gut health company Sun Genomics said on Monday that it has closed an $8.7 million Series A funding round.

The round was led by Pangaea Ventures, with additional investments from Danone Manifesto Ventures, SOSV, Human Longevity, and Nascita Ventures. Pangaea Ventures Founding General Partner Chris Erickson has also joined Sun Genomics' board of directors.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new analysis suggests warming, not the arrival of humans, led to the extinction of the woolly rhinoceros thousands of years ago, the Economist reports.

Chinese health officials uncovered SARS-CoV-2 viral RNA on imported frozen food, but the New York Times reports catching COVID-19 that way would be unlikely.

The UK has ordered 60 million coronavirus vaccine doses from Novavax and 30 million doses from Janssen, according to the Guardian.

In Science this week: machine learning model predicts whether ion channel mutations will cause disease, and more.